197 related articles for article (PubMed ID: 22389426)
1. Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.
Moody TW; Osefo N; Nuche-Berenguer B; Ridnour L; Wink D; Jensen RT
J Pharmacol Exp Ther; 2012 Jun; 341(3):873-81. PubMed ID: 22389426
[TBL] [Abstract][Full Text] [Related]
2. PYK-2 is tyrosine phosphorylated after activation of pituitary adenylate cyclase activating polypeptide receptors in lung cancer cells.
Moody TW; Di Florio A; Jensen RT
J Mol Neurosci; 2012 Nov; 48(3):660-6. PubMed ID: 22581436
[TBL] [Abstract][Full Text] [Related]
3. The G Protein-Coupled Receptor PAC1 Regulates Transactivation of the Receptor Tyrosine Kinase HER3.
Moody TW; Lee L; Jensen RT
J Mol Neurosci; 2021 Aug; 71(8):1589-1597. PubMed ID: 32964398
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenylate cyclase activating peptide receptors regulate the growth of non-small cell lung cancer cells.
Zia F; Fagarasan M; Bitar K; Coy DH; Pisegna JR; Wank SA; Moody TW
Cancer Res; 1995 Nov; 55(21):4886-91. PubMed ID: 7585525
[TBL] [Abstract][Full Text] [Related]
5. Pituitary adenylate cyclase-activating polypeptide causes increased tyrosine phosphorylation of focal adhesion kinase and paxillin.
Moody TW; Leyton J; Jensen RT
J Mol Neurosci; 2012 Jan; 46(1):68-74. PubMed ID: 21898124
[TBL] [Abstract][Full Text] [Related]
6. PAC1 regulates receptor tyrosine kinase transactivation in a reactive oxygen species-dependent manner.
Moody TW; Lee L; Iordanskaia T; Ramos-Alvarez I; Moreno P; Boudreau HE; Leto TL; Jensen RT
Peptides; 2019 Oct; 120():170017. PubMed ID: 30273693
[TBL] [Abstract][Full Text] [Related]
7. Pituitary adenylate cyclase activating polypeptide receptors are present on small cell lung cancer cells.
Moody TW; Zia F; Makheja A
Peptides; 1993; 14(2):241-6. PubMed ID: 8387187
[TBL] [Abstract][Full Text] [Related]
8. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
9. PACAP-27 tyrosine phosphorylates mitogen activated protein kinase and increases VEGF mRNAs in human lung cancer cells.
Moody TW; Leyton J; Casibang M; Pisegna J; Jensen RT
Regul Pept; 2002 Nov; 109(1-3):135-40. PubMed ID: 12409225
[TBL] [Abstract][Full Text] [Related]
10. Src-dependent TrkA transactivation is required for pituitary adenylate cyclase-activating polypeptide 38-mediated Rit activation and neuronal differentiation.
Shi GX; Jin L; Andres DA
Mol Biol Cell; 2010 May; 21(9):1597-608. PubMed ID: 20219970
[TBL] [Abstract][Full Text] [Related]
11. Bombesin receptor subtype-3 agonists stimulate the growth of lung cancer cells and increase EGF receptor tyrosine phosphorylation.
Moody TW; Sancho V; di Florio A; Nuche-Berenguer B; Mantey S; Jensen RT
Peptides; 2011 Aug; 32(8):1677-84. PubMed ID: 21712056
[TBL] [Abstract][Full Text] [Related]
12. Neurotensin receptors regulate transactivation of the EGFR and HER2 in a reactive oxygen species-dependent manner.
Moody TW; Lee L; Ramos-Alvarez I; Jensen RT
Eur J Pharmacol; 2019 Dec; 865():172735. PubMed ID: 31614143
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
14. Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells.
Moody TW; Ramos-Alvarez I; Moreno P; Mantey SA; Ridnour L; Wink D; Jensen RT
Peptides; 2017 Apr; 90():90-99. PubMed ID: 28153500
[TBL] [Abstract][Full Text] [Related]
15. Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development.
Borba JC; Henze IP; Silveira MS; Kubrusly RC; Gardino PF; de Mello MC; Hokoç JN; de Mello FG
Brain Res Dev Brain Res; 2005 May; 156(2):193-201. PubMed ID: 16099306
[TBL] [Abstract][Full Text] [Related]
16. Src family kinase inhibitors blunt PACAP-induced PAC1 receptor endocytosis, phosphorylation of ERK, and the increase in cardiac neuron excitability.
Tompkins JD; Clason TA; Buttolph TR; Girard BM; Linden AK; Hardwick JC; Merriam LA; May V; Parsons RL
Am J Physiol Cell Physiol; 2018 Feb; 314(2):C233-C241. PubMed ID: 29141923
[TBL] [Abstract][Full Text] [Related]
17. Neuromedin B receptors regulate EGF receptor tyrosine phosphorylation in lung cancer cells.
Moody TW; Berna MJ; Mantey S; Sancho V; Ridnour L; Wink DA; Chan D; Giaccone G; Jensen RT
Eur J Pharmacol; 2010 Jul; 637(1-3):38-45. PubMed ID: 20388507
[TBL] [Abstract][Full Text] [Related]
18. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
Apostolakis EM; Riherd DN; O'Malley BW
Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
[TBL] [Abstract][Full Text] [Related]
19. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells.
Li M; Funahashi H; Mbikay M; Shioda S; Arimura A
Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms involved in the protective effect of pituitary adenylate cyclase-activating polypeptide in an in vitro model of amyotrophic lateral sclerosis.
Maugeri G; D'Amico AG; Rasà DM; Federico C; Saccone S; Morello G; La Cognata V; Cavallaro S; D'Agata V
J Cell Physiol; 2019 Apr; 234(4):5203-5214. PubMed ID: 30238989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
